Howard Pan

Howard Pan has a diverse work experience in the biotechnology and pharmaceutical industry. Howard most recently served as the Director of Strategic and Biopharma Business Development, focusing on China and the APAC region, at Personalis, Inc. Prior to this, they worked at NanoString Technologies, Inc. where they held multiple roles including Senior Strategy Account Manager and APAC Pharma Liaison. In these roles, they collaborated with pharmaceutical companies and research organizations in the US and APAC region to develop innovative solutions for genomics, transcriptomics, and proteomics research. Before joining NanoString Technologies, Howard worked as a Territory Manager at Nexcelom Bioscience and as a Product Development Scientist at BioLegend, where they were involved in product development, quality verification, marketing, and sales strategy.

Howard Pan received their Ph.D in Molecular and Cellular Immunology from the Irell & Manella Graduate School of Biological Sciences, where they attended from 2006 to 2010. Prior to that, they obtained their B.S in Biotechnology from Tongji University, where they studied from 2002 to 2006. Before entering Tongji University, Pan attended Wuxi #1 High School from 1999 to 2002.